Department of Pharmacology, Basic College of Medicine, Jilin University, Changchun, People's Republic of China.
Cadre's Ward, The First Hospital of Jilin University, Changchun, People's Republic of China.
J Alzheimers Dis. 2021;84(2):557-578. doi: 10.3233/JAD-210595.
Glutamate is the main excitatory neurotransmitter in the brain, and its excitatory neurotoxicity is closely related to the occurrence and development of Alzheimer's disease. However, increasing evidence shows that in the process of Alzheimer's disease, glutamate is not only limited to its excitotoxicity as a neurotransmitter but also related to the disorder of its metabolic balance. The balance of glutamate metabolism in the brain is an important determinant of central nervous system health, and the maintenance of this balance is closely related to glutamate uptake, glutamate circulation, intracellular mitochondrial transport, and mitochondrial metabolism. In this paper, we intend to elaborate the key role of mitochondrial glutamate metabolism in the pathogenesis of Alzheimer's disease and review glutamate metabolism in mitochondria as a potential target in the treatment of Alzheimer's disease.
谷氨酸是大脑中的主要兴奋性神经递质,其兴奋性神经毒性与阿尔茨海默病的发生和发展密切相关。然而,越来越多的证据表明,在阿尔茨海默病的发生过程中,谷氨酸不仅局限于其作为神经递质的兴奋毒性,而且与代谢平衡紊乱有关。大脑中谷氨酸代谢的平衡是中枢神经系统健康的重要决定因素,维持这种平衡与谷氨酸摄取、谷氨酸循环、细胞内线粒体转运和线粒体代谢密切相关。本文旨在详细阐述线粒体谷氨酸代谢在阿尔茨海默病发病机制中的关键作用,并综述线粒体中谷氨酸代谢作为阿尔茨海默病治疗潜在靶点的研究进展。